ReviewInternational urogynecology journal2026
Holistic Pelvic Floor: Pelvic Floor Stress Dysfunction Diseases.
Review in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Female pelvic floor dysfunction diseases (PFD) comprise pelvic floor stress dysfunction diseases (PFSD) and non-pelvic floor stress dysfunction diseases (non-PFSD), with PFSD accounting for the majority of pelvic floor issues. PFSD is a group of diseases caused by pelvic floor stress support function injury and stress imbalance, mainly associated with pelvic floor support structure defects, weaknesses, injuries, pregnancy, transvaginal delivery, age, etc. A key to resolving PFSD lies in establishing the concept of holistic pelvic floor and therapeutic strategies based on functional pelvic floor biomechanics, etiology, and a holistic view of the disease. This article presents our perspective on current advances, challenges, and future directions in understanding and treating PFSD, emphasizing the need for a paradigm shift from symptom-oriented to mechanism-based management.
Indexed as
Identifiers
42101492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.